Chief Technology Officer @ (January 2022 - August 2023)
Senior Vice President Drug Discovery and Development @ Cygnal Therapeutics (November 2020 - November 2021)
Vice President Biologics Drug Development @ Cygnal Therapeutics (July 2019 - October 2020)
Director Biology, Discovery Partnerships with Academia @ (January 2016 - June 2019)
Director Biology, Virtual Proof of Concept @ (November 2013 - December 2015)
Director -Biologics Strategy, Cardiovascular Diseases @ (November 2004 - October 2013)
Postdoctoral fellow @ (January 2001 - December 2004)
Postdoctoral Fellow @ (January 1999 - December 2001)
Daniël Blom Education
University of Amsterdam
PhD (Biochemistry)
1994-1999
University of Amsterdam
MSc (Chemistry)
1989-1993
Daniël Blom Skills
Drug Discovery
In Vitro
Lifesciences
Biomarkers
Business Development
Marketing
Public Speaking
Daniël Blom Summary
Daniël Blom, based in Boston, MA, US, is currently a Chief Scientific Officer at Ampersand Biomedicines. Daniël Blom brings experience from previous roles at Ampersand Biomedicines, Cygnal Therapeutics and GSK. Daniël Blom holds a 1994 - 1999 PhD in Biochemistry @ University of Amsterdam. With a robust skill set that includes Drug Discovery, In Vitro, Lifesciences, Biomarkers, Business Development and more. Daniël Blom has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Daniël Blom?
Find contact details for 700 million professionals.